составить словообразовательную цепочку от слова дом
Главное меню:
Интересное
составить словообразовательную цепочку от слова дом, Active Psoriatic Arthritis (PsA) Treatment - TREMFYA, About TREMFYA® for PsA | TREMFYA® (guselkumab), What is Psoriatic Arthritis (PsA) | TREMFYA® (guselkumab), Tremfya Results | TREMFYA® (guselkumab), Official Consumer Website for TREMFYA® (guselkumab), TREMFYA® Cost & Savings Support for PsA | TREMFYA® (guselkumab), Tremfya (guselkumab).
of its kind for active PsATREMFYA® is a biologic treatment, and the first medication of its kind to be approved by the Food and Drug Administration (FDA) for adults with active psoriatic arthritis. TREMFYA® LegacyTREMFYA® has 15+ years of combined clinical research* and 7+ years on the market across indications.*Based on a clinical trial of TREMFYA® initiated in 2009.Results with TREMFYA®: less joint pain, stiffness, and swellingResults with TREMFYA®: less joint pain, stiffness,and swellingAt 24 weeksAt 24 weeksIn two medical studies, more than 5 out of 10 people who took TREMFYA® had at least a 20% improvement in active PsA symptoms (joint pain, stiffness, swelling) at 24 weeks compared to placebo. Individual results may vary.At 2 yearsAt 2 yearsOne medical study showed that less joint pain, stiffness, and swelling is possible even at 2 years.††For patients who continued on TREMFYA® for 2 years, a similar percentage (7 out of 10 patients) saw a 20% improvement in PsA symptoms at 2 years. At 24 weeks and thereafter, patients and healthcare providers knew that TREMFYA® was being used. This may have increased results. Individual results may vary.†For patients who continued on TREMFYA® for 2 years, a similar percentage (7 out of 10 patients) saw a 20% improvement in PsA symptoms at 2 years. At 24 weeks and thereafter, patients and healthcare providers knew that TREMFYA® was being used. This may have increased results. Individual results may vary.See More ResultsTREMFYA® Safety InformationAsk your doctor about the benefits and risks of TREMFYA®. Prescription medications, including TREMFYA®, have possible risks involved with treatment, so it’s important to discuss them with your doctor.What is the most important information I should know about TREMFYA®?TREMFYA® may cause serious side effects, including:Serious allergic reactions. Stop using TREMFYA® and get emergency medical help right away if you develop any of the following symptoms of a serious allergic reaction:fainting, dizziness, feeling lightheaded (low blood pressure)swelling of your face, eyelids, lips, mouth, tongue or throattrouble breathing or throat tightnesschest tightnessskin rash, hivesitchingfainting, dizziness, feeling lightheaded (low blood pressure)swelling of your face, eyelids, lips, mouth, tongue or throattrouble breathing or throat tightnesschest tightnessskin rash, hivesitchingInfections. TREMFYA® is a medicine that may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with TREMFYA® and may treat you for TB before you begin treatment with TREMFYA® if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with TREMFYA®.Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:fever, sweats, or chillscoughshortness of breath blood in your phlegm (mucus)muscle acheswarm, red, or painful skin or sores on your body different from your psoriasisweight lossdiarrhea or stomach painburning when you urinate or urinating more often than normalfever, sweats, or chillscoughshortness of breath blood in your phlegm (mucus)muscle acheswarm, red, or painful skin or sores on your body different from your psoriasisweight lossdiarrhea or stomach painburning when you urinate or urinating more often than normalLiver problems. With the treatment of Crohn’s disease or ulcerative colitis, your healthcare provider will do blood tests to check your liver before and during treatment with TREMFYA®. Your healthcare provider may stop treatment with TREMFYA® if you develop liver problems. Tell your healthcare provider right away if you notice any of the following symptoms:unexplained rashvomitingtiredness (fatigue)yellowing of the skin or the whites of your eyesnauseastomach pain (abdominal)loss of appetitedark urineunexplained rashvomitingtiredness (fatigue)yellowing of the skin or the whites of your eyesnauseastomach pain (abdominal)loss of appetitedark urineThese are not all the possible side effects of TREMFYA®.Please read the Important Safety Information located at the bottom of the screen and the Medication Guide for TREMFYA® to learn more about these and other risks for TREMFYA®. Discuss any questions you have with your doctor.What are the most common side effects of TREMFYA®?TREMFYA® may cause serious side effects including:See “What is the most important information I should know about TREMFYA®?”The most common side effects of TREMFYA® include:respiratory tract infectionsjoint pain (arthralgia)fungal skin infectionsbronchitisheadachediarrheaherpes simplex infectionsinjection site reactionsstomach flu (gastroenteritis)stomach painrespiratory tract infectionsjoint pain (arthralgia)fungal skin infectionsbronchitisheadachediarrheaherpes simplex infectionsinjection site reactionsstomach flu (gastroenteritis)stomach painThese are not all the possible side effects of TREMFYA®. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088., WHAT IS TREMFYA® (guselkumab)? TREMFYA ® is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light). TREMFYA ® is a prescription medicine used to treat adults with active psoriatic arthritis., TREMFYA ® is a biologic treatment, and the first medication of its kind to be approved by the Food and Drug Administration (FDA) for adults with active psoriatic arthritis..
Because psoriatic arthritis is presented differently in different people, healthcare providers should work with their patients to develop an appropriate treatment plan. Is there a link between psoriatic arthritis and plaque psoriasis? 85% of people with psoriatic arthritis develop thick, red patches on their skin before experiencing joint symptoms., TREMFYA ® is a prescription medicine approved for the treatment of adults with active psoriatic arthritis (PsA). In two medical studies, more than half of patients treated with TREMFYA ® had at least a 20% improvement in PsA symptoms (joint pain, stiffness, swelling) at 24 weeks compared to placebo., WHAT IS TREMFYA® (guselkumab)? TREMFYA ® is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light). TREMFYA ® is a prescription medicine used to treat adults with active psoriatic arthritis., WHAT IS TREMFYA® (guselkumab)? TREMFYA ® is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light). TREMFYA ® is a prescription medicine used to treat adults with active psoriatic arthritis., Tremfya (guselkumab) For adults with active psoriatic arthritis welling at 24 weeks. Individ TREMFYA® is a prescription medicine used to treat adults with active psoriatic arthritis., TREMFYA ® is the first medication of its kind to be approved by the Food and Drug Administration (FDA) in 2017 to treat adults with moderate to severe plaque psoriasis. In July 2020, the FDA also approved TREMFYA ® to treat adults with active psoriatic arthritis..